![](https://ml.globenewswire.com/media/02c4072d-9fea-4ff1-bd39-1b5405586ad1/small/20170126-knightl-jpg.jpg)
Knight Therapeutics Announces CVM Approval of the Tender Offer for remaining 48.8% of Grupo Biotoscana
MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. ("Knight" or “Offeror”) today announced that the Brazilian Securities and Exchange Commission (Comissão de Valores …